LEXICON PHARMACEUTICALS INC. - COMMON STOCK

Lexicon Announces Series of Presentations Relating to LX9211, Its Investigational Drug for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)

07 9 2023 09:00:00 提供 Nasdaq GlobeNewswire

Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023

21 8 2023 09:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

17 8 2023 09:45:24 提供 NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

16 8 2023 09:45:10 提供 NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

15 8 2023 10:01:50 提供 NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

14 8 2023 09:45:43 提供 NetDania Notify

Published Analysis of Sotagliflozin (INPEFA(TM)) Clinical Data Demonstrates Significant Reductions in the Risk of Hospital Readmissions for Heart Failure

08 8 2023 09:00:01 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

07 8 2023 13:43:27 提供 NetDania Notify

Lexicon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

03 8 2023 16:01:00 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 3, 2023

28 7 2023 16:01:00 提供 Nasdaq GlobeNewswire

Lexicon Elects Diane E. Sullivan to Board of Directors

28 7 2023 08:00:00 提供 Nasdaq GlobeNewswire

Lexicon Announces Planned Advancement of LX9211 Into Late-Stage Development

23 6 2023 20:45:00 提供 Nasdaq GlobeNewswire

Lexicon to Present Study Results Relating to LX9211 and INPEFA™ (Sotagliflozin) at the American Diabetes Association’s 83rd Scientific Sessions

20 6 2023 08:00:02 提供 Nasdaq GlobeNewswire

UPDATE: Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

15 6 2023 17:00:30 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in the Jefferies 2023 Global Healthcare Conference

06 6 2023 16:01:00 提供 Nasdaq GlobeNewswire

Lexicon Announces Closing of Public Offering and Concurrent Private Placement, Including Full Exercise of Options to Purchase Additional Shares

05 6 2023 16:01:00 提供 Nasdaq GlobeNewswire

Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement

01 6 2023 08:00:01 提供 Nasdaq GlobeNewswire

Lexicon Announces Proposed Public Offering of Common Stock

31 5 2023 16:01:00 提供 Nasdaq GlobeNewswire

Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

26 5 2023 16:05:00 提供 Nasdaq GlobeNewswire

New Analysis Finds Sotagliflozin to Be a Cost-Effective Treatment at Commonly Accepted Willingness-to-Pay Threshold in Patients with Worsening Heart Failure

10 5 2023 16:30:00 提供 Nasdaq GlobeNewswire